TOI insider trading
HealthcareStarling Oncology, Inc.: insider trade history from SEC Form 4 filings.
About Starling Oncology, Inc.
The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, counseling services, and 24/7 patient assistance services. The company also provides and manages clinical trials, palliative care programs, stem cell transplants services, other care delivery models associated with non-community-based academic, and tertiary care settings; and conducts clinical trials for a range of pharmaceutical, and medical device companies. It serves adult and senior cancer patients. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.
Company website: theoncologyinstitute.com
TOI insider activity at a glance
FilingIQ tracks 339 insider transactions for TOI in filings since Nov 16, 2021. The most recent transaction is dated Jul 27, 2026.
Across the full history, 43 open-market purchases
and 98 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on TOI insider trades is 53.7/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest TOI Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Frequently asked
- How many insider trades does FilingIQ track for TOI?
- FilingIQ tracks 339 Form 4 insider transactions for TOI (Starling Oncology, Inc.), covering filings from Nov 16, 2021 onwards. 13 of those are dated within the last 90 days.
- Are TOI insiders net buyers or net sellers?
- Across the full Form 4 history for TOI, 43 transactions (13%) were open-market purchases and 98 (29%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does TOI insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
- What sector is TOI in?
- Starling Oncology, Inc. (TOI) is classified in the Healthcare sector, specifically Medical Care Facilities, with a current market capitalisation of $246.94M.
Methodology & sources
Every TOI insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.